Hepatitis B virus with primary resistance to adefovir [11]

New England Journal of Medicine

Volumn 355, Issue 3, 2006, Pages 322-323

  Chang, Ting Tsung ^a   Lai, Ching Lung ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B(E) ANTIGEN; ISOLEUCINE; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; TENOFOVIR; VALINE;

CHRONIC HEPATITIS; DISEASE SEVERITY; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LETTER; LIVER BIOPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

ADENINE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GUANINE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MUTATION; PHOSPHONIC ACIDS; VIRAL LOAD;

EID: 33746047105     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc066267     Document Type: Letter

References (3)

1. Schildgen O, Sirma H, Funk A, et al. Variant of hepatitis B virus with primary resistance to adefovir. N Engl J Med 2006; 354:1807-12.
2. Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354:1001-10.
3. Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006;354:1011-20. [Erratum, N Engl J Med 2006;354:1863.]